Abstract:disease (CHD) or atherosclerosis is elevated levels of serum cholesterol. Recent clinical trials and studies have confirmed that lowering of low-density lipoprotein (LDL) cholesterol is related to a reduction in CHD risk. The reduction of serum cholesterol levels has mainly been accomplished by inhibiting cholesterol biosynthesis or by blocking the absorption of dietary cholesterol. Statins, such as pravastatin, that effectively inhibit cholesterol biosynthesis are HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase) inhibitors and are widely prescribed in the treatment of hypercholesterolemia. Several squalene synthesis inhibitors have been also reported. SCH-48461 (a trans-azetidinone) and 4 ,6 -bis((2-fluorophenyl)carbamoyl) b-O-cellobioside (a steriodal glycoside) have recently been reported to be cholesterol absorption inhibitors. Phytosterols, or plant sterols, are an interesting class of compound due to their application and biological activities. The phytosterols found most frequently in nature are b-sitosterol, campesterol, and stigmasterol. It has been known that they inhibit the absorption of dietary and endogenously produced cholesterol from the small intestine, reducing blood cholesterol concentrations both in animal models and in humans. b-Sitosterol and b-sitostanol fatty acid esters were recently commercialized as food additives to reduce serum cholesterol levels. A novel hydrophilic phytostanol analogue, FM-VP4, was also developed to reduce serum cholesterol levels. However, even with the current therapeutic agents, it is not easy to achieve proper plasma cholesterol levels without side effect. Therefore the discovery of more effective, well-tolerated agents that reduce high cholesterol levels is needed. We here report the synthesis and interesting pharmacologic properties of novel succinamic acid ester derivatives that are bsitosterol analogues, compounds 1 and 2, that have the ability to lower plasma cholesterol levels and that can be more effective cholesterol-lowering alternatives to b-sitosterol and bsitostanol fatty acid esters. Chemistry The synthesis of b-sitosterol analogues 1 and 2 are summarized Chart 1. The b-sitosterol-3-hemisuccinate ester 1 was prepared by the reaction of b-sitosterol and succinic anhydride in toluene with a catalytic amount of DMAP. The chlorination of the resulting acid compound 1 with SOCl2 and then direct amination with appropriate amines afforded N-substituted succinamic acid b-sitosteryl ester derivatives 2. Compounds 2 were also synthesized in 76—92% yields by the reaction of 1 with methyl chloroformate, followed by amination of the activated intermediate. Interestingly, compound 2a (DANA87) was also easily obtained in one step by the direct addition of b-sitosterol to dicyclohexylcarbodiimide (DCC) in 80% yield. It was considered that compound DANA87 was prepared by slow thermal degradation of the May 2004 Notes Chem. Pharm. Bull. 52(5) 597—601 (2004) 597

Synthesis of cholesterol analogues and comparison on their effect on plasma cholesterol with β-Sitosterol

Sudden hearing loss: a clinical survey.

Cholesterol side chain analogs but not its ether analogs possess cholesterol-lowering activity.

Intake of Stigmasterol and Β-Sitosterol Alters Lipid Metabolism and Alleviates NAFLD in Mice Fed a High-Fat Western-Style Diet.

Effects of Stigmasterol and Β-Sitosterol on Nonalcoholic Fatty Liver Disease in a Mouse Model: A Lipidomic Analysis.

Fatty Acid Moieties Have Little Effect on Cholesterol‐lowering Potency of Plant Sterol Esters

Bioactivity, Synthesis, Extraction and Analysis of Sterol Ferulate: A Review

Plasma Cholesterol-Raising Potency of Dietary Free Cholesterol Versus Cholesteryl Ester and Effect of Β-Sitosterol.

β-Sitosterol and stigmasterol ameliorate dextran sulfate sodium-induced colitis in mice fed a high fat Western-style diet.

Blockage of Hydroxyl Group Partially Abolishes the Cholesterol-Lowering Activity of Β-Sitosterol

Effect of a New b-Sitosterol Analogue on Plasma Lipid Concentrations in Rats 1 )

Investigation into the Synthesis of C-25 Oxysterols

Phytosterol Organic Acid Esters: Characterization, Anti-Inflammatory Properties and a Delivery Strategy to Improve Mitochondrial Function

Plasma Cholesterol-Lowering Activity of Dietary Dihydrocholesterol in Hypercholesterolemia Hamsters

Differences between phytosterols with different structures in regulating cholesterol synthesis, transport and metabolism in Caco-2 cells

Enhancement of Galloylation Efficacy of Stigmasterol and Β-Sitosterol Followed by Evaluation of Cholesterol-Reducing Activity.

Dura mater value for cardiac prosthesis.

The Zollinger‐Ellison Syndrome: Re‐appraisal and Evaluation of 260 Registered Cases

The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism

Impact of molecular interactions between hydrophilic phytosterol glycosyl derivatives and bile salts on the micellar solubility of cholesterol

Effect of β-sitosterol self-microemulsion and β-sitosterol ester with linoleic acid on lipid-lowering in hyperlipidemic mice